Work

Plasma levels of tumour necrosis factor alpha and interleukin‐6 predict progression‐free survival following thalidomide therapy in patients with previously untreated multiple myeloma

Year: 2003

Type: article

Source: British Journal of Haematology

DOI: 10.1046/j.1365-2141.2003.04605.x

Authors: Michael A. Thompson, Thomas E. Witzig, Shaji Kumar, Michael M. Timm, Jessica Haug, Rafael Fonseca, Philip R. Greipp, John A. Lust, S. Vincent Rajkumar

Institution: Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1682993711, G309468089, Angiogenesis and thalidomide therapy in multiple myeloma, ANGIOGENESIS AND ANGIOGENIC CYTOKINES IN MYELOMA, G7585679282, Studies on Monoclonal Gammopathies

OpenAlex ID: W2084719782

FWCI: 1.418

Cites: 9

Cited by: 31

Related to: 10